STAT5A and neoplasm: Enhanced STAT5 signaling was also linked to overexpression of oncogenic miR-155 in CTCL [86], associated with downregulation of tumor-suppressive miR-22 [87], or enhanced disease progression caused by Lymphotoxin-α-dependent lymphangiogenesis [88].